BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32475772)

  • 1. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma.
    Elshaikh MA; Modh A; Jhingran A; Biagioli MC; Coleman RL; Gaffney DK; Harkenrider MM; Heskett K; Jolly S; Kidd E; Lee LJ; Li L; Portelance L; Sherertz T; Venkatessan AM; Wahl AO; Yashar CM; Small W
    Gynecol Oncol; 2020 Aug; 158(2):460-466. PubMed ID: 32475772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas.
    Sherertz T; Jhingran A; Biagioli M; Gaffney D; Elshaikh M; Coleman RL; Harkenrider M; Kidd EA; Jolly S; Yashar C; Portelance L; Wahl A; Venkatesan A; Li L; Small W;
    Int J Gynecol Cancer; 2022 Dec; 32(12):1549-1554. PubMed ID: 36423958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Recommended Treatment of Uterine Carcinosarcoma.
    Menczer J
    Curr Treat Options Oncol; 2015 Nov; 16(11):53. PubMed ID: 26374341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare uterine cancer: carcinosarcomas. Review from histology to treatment.
    Artioli G; Wabersich J; Ludwig K; Gardiman MP; Borgato L; Garbin F
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):98-104. PubMed ID: 25468677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
    Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
    Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
    Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
    Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.
    Matsuo K; Omatsu K; Ross MS; Johnson MS; Yunokawa M; Klobocista MM; Im DD; Bush SH; Ueda Y; Takano T; Blake EA; Hasegawa K; Baba T; Shida M; Satoh S; Yokoyama T; Machida H; Adachi S; Ikeda Y; Iwasaki K; Miyake TM; Yanai S; Nishimura M; Nagano T; Takekuma M; Takeuchi S; Pejovic T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
    Gynecol Oncol; 2017 Apr; 145(1):78-87. PubMed ID: 28215838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine carcinosarcomas: From pathology to practice.
    Toboni MD; Crane EK; Brown J; Shushkevich A; Chiang S; Slomovitz BM; Levine DA; Dowdy SC; Klopp A; Powell MA; Thaker PH
    Gynecol Oncol; 2021 Jul; 162(1):235-241. PubMed ID: 34030871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine carcinosarcoma: A review of the literature.
    Cantrell LA; Blank SV; Duska LR
    Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.
    Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
    Surg Oncol; 2019 Jun; 29():25-32. PubMed ID: 31196490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma.
    Galaal K; Kew FM; Tam KF; Lopes A; Meirovitz M; Naik R; Godfrey KA; Hatem MH; Edmondson RJ
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):88-92. PubMed ID: 19201517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis.
    Stokes WA; Robin TP; Jackson MW; Amini A; Schefter TE; Lefkowits CC; Fisher CM
    Am J Clin Oncol; 2018 Oct; 41(10):927-932. PubMed ID: 28654573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).
    Cha J; Kim YS; Park W; Kim HJ; Kim JY; Kim JH; Kim J; Yoon WS; Kim JW; Kim YB
    J Gynecol Oncol; 2016 Nov; 27(6):e58. PubMed ID: 27550404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics, Surgical Management and Adjuvant Therapy of Patients with Uterine Carcinosarcoma: A Retrospective Case Series.
    Wallwiener C; Hartkopf A; Kommoss S; Joachim C; Wallwiener M; Taran FA; Brucker S
    Geburtshilfe Frauenheilkd; 2016 Feb; 76(2):188-193. PubMed ID: 26941453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.